dismissed EB-2 (NIW)
Chief Executive /Entrepreneur
Pharmaceutical Sector · 2024-09-24
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.
Proposed Endeavor
The petitioner proposes to start a company dedicated to developing a digital learning platform for pharmaceutical sales professionals. This endeavor aims to enhance specialized knowledge in ophthalmology-related pharmaceutical products, supporting economic growth, better health outcomes, healthcare efficiency, and patient safety.
Framework Evaluation
0 of 3 criteria met1 Proposed endeavor has substantial merit and national importance Not Met
The proposed endeavor was found to have substantial merit, but the Petitioner failed to establish its national importance, as projections lacked support and expert letters were insufficient.
Why This Petition Was Denied
The motion was dismissed because the Petitioner failed to establish that the proposed endeavor has national importance, which is a requirement for Prong 1 of the Dhanasar framework. While the business plan projected 28 jobs and over one million dollars in revenue, these projections lacked supporting details. Expert letters were deemed insufficient to demonstrate broader implications or substantial positive economic effects beyond the company's clientele, and the argument regarding a national shortage was not adequately linked to the proposed endeavor's impact.
Evidence
Evidence Types
Reference Letters Independent
Commercial Success
Job Creation Estimates
Government Alignment
Similar Cases
Chief Executive Officer (CEO)
Pharmaceuticals
USCIS EB-2 (NIW) rfe dismissed
Florida 2024-04-19
The petitioner proposes to launch and develop a Florida-based company focused on a digital learning and instruction platform for pharmaceutical sales professionals. The endeavor involves coaching sales teams and developing commercial chains for American products, specifically in ophthalmology-related pharmaceuticals, to help U.S. companies reach international markets.
Chief Executive Officer (CEO)
Consulting · Brazil
USCIS EB-2 (NIW) rfe dismissed
Florida 2025-01-30
The petitioner proposes to serve as the CEO of a consulting firm providing comprehensive services to U.S. medical device manufacturers to expand their export-based activities. The endeavor involves establishing integrated sales strategies, operations, and investments to open international markets, specifically targeting Brazil, Latin America, and Asia. The work focuses on managing administrative and commercial aspects of exports and navigating complex foreign regulatory requirements.
Others
Pharmaceuticals · India
USCIS EB-2 (NIW) dismissed
2024-11-18
The Beneficiary proposes to continue working as an Associate Director, Master Data Management (MDM) Implementation Lead for a pharmaceutical company. His endeavor involves developing, implementing, and managing digital platforms using AI and machine learning to optimize laboratory workflows, integrate clinical trial data, ensure data security, improve access to high-quality information, and accelerate drug research, development, and regulatory approval processes.
Others
Pharmaceuticals
USCIS EB-2 (NIW) dismissed
2024-10-21
The Beneficiary proposes to streamline and ensure the quality of pharmaceutical research, development, and regulatory approval processes through the development, enhancement, and maintenance of cloud, DevOps, and database systems. This involves enhancing clinical data management systems to automate drug development, protect sensitive patient data, and integrate cloud and AI automation technologies to optimize the process.
Frequently Asked Questions
A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-09-24.
Browse all casesAt a Glance
Outcome dismissed
Criteria Met 0 / 3
Evidence Types 4
EB-2 (NIW) Case Data
Scraped Case Data
Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist